ReviewNeuropsychiatric disease and treatment2026
Traditional Chinese Medicine Interventions for Antipsychotic-Induced Extrapyramidal Symptoms: A Data Mining-Based Integrative Review of Prescription Patterns and Evidence.
Review in Neuropsychiatric disease and treatment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Antipsychotic-induced extrapyramidal symptoms (EPS), including drug-induced parkinsonism, akathisia, dystonia, and tardive dyskinesia, remain major limitations of long-term antipsychotic therapy and negatively affect treatment adherence and quality of life. Traditional Chinese Medicine (TCM) has increasingly been explored as an adjunctive strategy for EPS management; however, evidence regarding prescription patterns, clinical effectiveness, and mechanistic rationale remains fragmented. Objective: To conduct an integrative review of TCM interventions for antipsychotic-induced EPS through synthesis of clinical evidence and quantitative analysis of prescription patterns. Methods: A systematic search of English- and Chinese-language databases identified 31 eligible studies, including randomized controlled trials, non-randomized studies, and cohort investigations. Clinical characteristics, EPS subtypes, outcome measures, safety data, and herbal prescription components were extracted. Narrative evidence synthesis was combined with frequency analysis, association rule mining, clustering, and network mapping to identify recurrent herbal combinations and therapeutic structures. Results: Included studies involved patients with schizophrenia-spectrum disorders receiving first- or second-generation antipsychotics. Drug-induced parkinsonism and tardive dyskinesia were the most frequently evaluated EPS subtypes. Frequently prescribed herbs included Conclusion: Current evidence suggests that adjunctive TCM interventions may provide symptomatic benefit for antipsychotic-induced EPS, particularly drug-induced parkinsonism and tardive dyskinesia. Nevertheless, existing evidence remains preliminary and geographically concentrated, and higher-quality multicenter studies with standardized reporting and long-term safety evaluation are required before broader clinical implementation can be recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.